Monday, March 17th, 2025 — Pre-Conference Workshops - EST/EDT (Eastern Daylight, GMT-4)
Strategize on best practices in collaborating with hospital systems and research organizations to advance access and treatment development
Uncover specific challenges and success stories in funding clinical trials and research through a consortium of pediatric hospitals across the country
Learn more about the TORCH initiative, its $2 million annual funding goal and how it is creating innovation at both the hospital and local level
- Erin Santos Primis - President, Isabella Santos Foundation
- Andrew Satterlee, PhD - Assistant Professor, Director of the Screening Live Cancer Explants Program, University of North Carolina at Chapel Hill
- Erin Finucane - Founder, Erin Finucane & Co
This session explores the rise of AFPs and specialty carve-outs, analyzing how these programs affect the pharmaceutical landscape, patient affordability and access to specialty medications. Discuss the legal, regulatory and financial ramifications, offering strategies for pharmaceutical companies to challenge these programs and protect market share.
- Jonathan James - Chief Executive Officer, Hope Charities
- Discuss advancements in AI and how the technology can be applied to drive meaningful change in the patient experience
- Participate in a highly interactive session designed to navigate the complex challenges facing the patient experience, identifying areas where AI could transform the status quo
- Generate and prioritize AI-led product concepts to improve patient access, adherence and experience
- Sam Dix - New Ventures, Offline Studio
- Ethan Wergelis-Isaacson - Strategy and Partnerships, Offline Studio
Discuss working with ambassador programs, engagement campaigns and efforts to increase community involvement
Establish strong advocate networks and create communication strategies that resonate with communities
Understand how to balance long-term planning with need for nimble, real-time response to critical issues
- Michele Guadalupe - Director of Advocacy and Access, National Eczema Association
As AFPs increasingly divert patients away from traditional coverage models, pharmaceutical companies must develop strategies to safeguard patient access to essential treatments. This session focuses on building robust patient assistance programs, collaborating with payers and ensuring compliance, while addressing the challenges posed by specialty carve-outs, including how AFPs are evolving their business models and tactics based on observations.
- Rachel Klein - Deputy Executive Director, The AIDs Institute
- Kevin Herwig - Health Policy Manager, HIV + Hepatitis Policy Institute
**Attendee qualification and approval for this session is at the discretion of Informa Connect.
Participants engage in a structured brainstorming session to:
- Identify key challenges and barriers to healthcare delivery, access and patient support as discussed earlier in the workshop
- Generate innovative solutions using AI and emerging technologies, including but not limited to:
- Develop and pitch new venture ideas
- Sam Dix - New Ventures, Offline Studio
- Ethan Wergelis-Isaacson - Strategy and Partnerships, Offline Studio